4.6 Article

OMIT: Dynamic, Semi-Automated Ontology Development for the microRNA Domain

Journal

PLOS ONE
Volume 9, Issue 7, Pages -

Publisher

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0100855

Keywords

-

Funding

  1. NIH [R01-CA149646]
  2. Vincent F. Kilborn, Jr. Cancer Research Foundation
  3. NSF by Division of Molecular and Cellular Biosciences [1350064]
  4. NSF EPSCoR program
  5. Div Of Molecular and Cellular Bioscience
  6. Direct For Biological Sciences [1350064] Funding Source: National Science Foundation

Ask authors/readers for more resources

As a special class of short non-coding RNAs, microRNAs (a. k. a. miRNAs or miRs) have been reported to perform important roles in various biological processes by regulating respective target genes. However, significant barriers exist during biologists' conventional miR knowledge discovery. Emerging semantic technologies, which are based upon domain ontologies, can render critical assistance to this problem. Our previous research has investigated the construction of a miR ontology, named Ontology for MIcroRNA Target Prediction (OMIT), the very first of its kind that formally encodes miR domain knowledge. Although it is unavoidable to have a manual component contributed by domain experts when building ontologies, many challenges have been identified for a completely manual development process. The most significant issue is that a manual development process is very labor-intensive and thus extremely expensive. Therefore, we propose in this paper an innovative ontology development methodology. Our contributions can be summarized as: (i) We have continued the development and critical improvement of OMIT, solidly based on our previous research outcomes. (ii) We have explored effective and efficient algorithms with which the ontology development can be seamlessly combined with machine intelligence and be accomplished in a semi-automated manner, thus significantly reducing large amounts of human efforts. A set of experiments have been conducted to thoroughly evaluate our proposed methodology.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Biochemistry & Molecular Biology

Mouse Genome Informatics (MGI): latest news from MGD and GXD

Martin Ringwald, Joel E. Richardson, Richard M. Baldarelli, Judith A. Blake, James A. Kadin, Cynthia Smith, Carol J. Bult

Summary: The Mouse Genome Informatics (MGI) database system combines expertly curated community data resources to facilitate the use of the mouse as an experimental model for understanding human health and disease genetics. MGI is the authoritative source for mouse gene information, maintains standard ontologies, and contributes to the development of gene and disease ontologies.

MAMMALIAN GENOME (2022)

Article Substance Abuse

Regular Kratom (Mitragyna speciosa Korth.) Use and Its Association With Endoplasmic Reticulum Stress Response

Nurul Atiqahd Muhamad Fauzi, Mei Lan Tan, Shahrul Bariyah Sahul Hamid, Darshan Singh, Mohammad Farris Iman Leong Bin Abdullah

Summary: This study found an association between the expression of ER stress sensor mRNA in peripheral leukocytes and patterns of kratom use. It also identified correlations between the levels of ER stress sensor mRNA and the severity of kratom dependence and kratom induced depressive symptoms.

JOURNAL OF ADDICTION MEDICINE (2022)

Article Cell Biology

MicroRNA-like snoRNA-Derived RNAs (sdRNAs) Promote Castration-Resistant Prostate Cancer

Alexander B. Coley, Ashlyn N. Stahly, Mohan Kasukurthi, Addison A. Barchie, Sam B. Hutcheson, Dominika Houserova, Yulong Huang, Brianna C. Watters, Valeria M. King, Meghan A. Dean, Justin T. Roberts, Jeffrey D. DeMeis, Krisha Amin, Cameron H. McInnis, Noel L. Godang, Ryan M. Wright, David F. Haider, Neha B. Piracha, Cana L. Brown, Zohaib M. Ijaz, Shengyu Li, Yaguang Xi, Oliver G. McDonald, Jingshan Huang, Glen M. Borchert

Summary: This study identified differentially expressed snoRNA fragments in prostate cancer patients and found that two specific fragments, sdRNA-D19b and -A24, play important roles in promoting proliferation, migration, and chemotherapeutic resistance in prostate cancer. The targets of sdRNA-D19b and sdRNA-A24 were identified as tumor suppressor genes CD44 and CDK12, respectively.

CELLS (2022)

Article Cell Biology

Epithelial-Mesenchymal Transition Suppresses AMPK and Sensitizes Cancer Cells to Pyroptosis under Energy Stress

Mingwei Liang, Jennifer W. Li, Huacheng Luo, Sarah Lulu, Ozlem Calbay, Anitha Shenoy, Ming Tan, Brian K. Law, Shuang Huang, Tsan Sam Xiao, Hao Chen, Lizi Wu, Jia Chang, Jianrong Lu

Summary: This study found that EMT suppresses the expression of AMPK genes and affects AMPK activation, leading to increased sensitivity of cancer cells to pyroptotic cell death under energy stress conditions. AMPK expression in tumors is associated with clinical prognosis. EMT-induced collateral vulnerabilities may be therapeutically exploited.

CELLS (2022)

Review Biochemistry & Molecular Biology

Small Nucleolar Derived RNAs as Regulators of Human Cancer

Alexander Bishop Coley, Jeffrey David DeMeis, Neil Yash Chaudhary, Glen Mark Borchert

Summary: In the past decade, sdRNAs derived from snoRNAs have emerged as important regulators in cancer gene expression. They possess miRNA-like functions and can act as oncogenic or tumor-suppressing RNAs depending on the tissue context. Despite being frequently overlooked in non-coding RNA analyses, sdRNAs represent a subclass of miRNAs that deserve further study to uncover their underlying biology and identify potential biomarkers and therapeutic targets for various human cancers.

BIOMEDICINES (2022)

Article Multidisciplinary Sciences

MicroRNAs within the Basal-like signature of Quadruple Negative Breast Cancer impact overall survival in African Americans

Anusha Angajala, Hughley Raymond, Aliyu Muhammad, Md Shakir Uddin Ahmed, Saadia Haleema, Monira Haque, Honghe Wang, Moray Campbell, Rachel Martini, Balasubramanian Karanam, Andrea G. Kahn, Deepa Bedi, Melissa Davis, Ming Tan, Windy Dean-Colomb, Clayton Yates

Summary: The study revealed that QNBC tumors are more common in African Americans compared to TNBC tumors. By analyzing miRNA and mRNA expression data, it was found that QNBC patients have an altered gene signature associated with racial disparity and poor survival.

SCIENTIFIC REPORTS (2022)

Article Cell Biology

MST4: A Potential Oncogene and Therapeutic Target in Breast Cancer

Ritu Arora, Jin-Hwan Kim, Ayechew A. Getu, Anusha Angajala, Yih-Lin Chen, Bin Wang, Andrea G. Kahn, Hong Chen, Latif Reshi, Jianrong Lu, Wenling Zhang, Ming Zhou, Ming Tan

Summary: The highly expressed MST4 gene in breast cancer promotes cell growth, migration, invasion, and epithelial-mesenchymal transition (EMT). It is associated with cancer stage, lymph node metastasis, and poor overall survival.

CELLS (2022)

Article Oncology

The mammalian Sterile 20-like kinase 4 (MST4) signaling in tumor progression: Implications for therapy

Ayechew A. Getu, Ming Zhou, Shi-Yuan Cheng, Ming Tan

Summary: Cancer, a complex and dynamic disease, remains a leading cause of death in humans. The Mammalian Sterile 20-Like Kinase 4 (MST4 or STK26) plays a crucial role in cell migration and polarity, and is involved in various processes such as tumor cell proliferation, migration, invasion, survival, and cancer metastasis. MST4 interacts with PDCD10 to promote tumor growth and migration, and phosphorylates ATG4B to mediate autophagy signaling and contribute to treatment resistance. Overall, MST4 functions as an oncogene and shows potential as a therapeutic target.

CANCER LETTERS (2023)

Review Biochemistry & Molecular Biology

New frontiers in immune checkpoint B7-H3 (CD276) research and drug development

Ayechew Adera Getu, Abiye Tigabu, Ming Zhou, Jianrong Lu, Oystein Fodstad, Ming Tan

Summary: B7-H3 is a crucial factor in cancer progression, with selective expression in tumor cells and immune cells. It is involved in tumor cell proliferation, metastasis, and therapeutic resistance. Targeting B7-H3 offers cancer-specific toxicity and minimal harm to healthy cells, making it a promising target for cancer therapy.

MOLECULAR CANCER (2023)

Article Cell Biology

BRD7 inhibits enhancer activity and expression of BIRC2 to suppress tumor growth and metastasis in nasopharyngeal carcinoma

Mengna Li, Yanmei Wei, Yukun Liu, Jianxia Wei, Xiangting Zhou, Yumei Duan, Shipeng Chen, Changning Xue, Yuting Zhan, Lemei Zheng, Hongyu Deng, Faqing Tang, Songqing Fan, Wei Xiong, Guiyuan Li, Ming Tan, Ming Zhou

Summary: BRD7 functions as a tumor suppressor by negatively regulating the enhancer activity and expression of BIRC2 in nasopharyngeal carcinoma. BIRC2 promotes tumor growth and metastasis, and its expression is negatively correlated with BRD7 expression in NPC tissues. Targeting the BRD7/BIRC2 regulation axis could be a potential strategy for NPC diagnosis and treatment.

CELL DEATH & DISEASE (2023)

Review Cell Biology

Targeting ARID1A-Deficient Cancers: An Immune-Metabolic Perspective

Timofey Lebedev, Rubina Kousar, Bbumba Patrick, Muhammad Usama, Meng-Kuei Lee, Ming Tan, Xing-Guo Li

Summary: Epigenetic remodeling and metabolic reprogramming are two highly intertwined cancer hallmarks. Recent studies have shown that the interplay between epigenetic regulation and metabolic rewiring can be targeted as a potential Achilles' heel in cancer. This review explores the immunomodulatory role of ARID1A and summarizes the advances in targeting ARID1A-deficient cancers to improve patient outcome by harnessing the immune-metabolic vulnerability.

CELLS (2023)

Article Biochemistry & Molecular Biology

Umbelliferone and eriodictyol suppress the cellular entry of SARS-CoV-2

Fang-Ju Cheng, Chien-Yi Ho, Tzong-Shiun Li, Yeh Chen, Yi-Lun Yeh, Ya-Ling Wei, Thanh Kieu Huynh, Bo-Rong Chen, Hung-Yu Ko, Chen-Si Hsueh, Ming Tan, Yang-Chang Wu, Hui-Chi Huang, Chih-Hsin Tang, Chia-Hung Chen, Chih-Yen Tu, Wei-Chien Huang

Summary: Two phytochemicals found in Artemisia argyi, eriodictyol and umbelliferone, have been shown to suppress the cellular entry of SARS-CoV-2 by preventing the binding of the S protein to ACE2. Umbelliferone also effectively prevents inflammation in lung tissues caused by SARS-CoV-2 infection.

CELL AND BIOSCIENCE (2023)

Review Oncology

Heat Shock Factor 1 Inhibition: A Novel Anti-Cancer Strategy with Promise for Precision Oncology

Khanisyah Erza Gumilar, Yeh Chin, Ibrahim Haruna Ibrahim, Brahmana A. Tjokroprawiro, Jer-Yen Yang, Ming Zhou, Natalie R. Gassman, Ming Tan

Summary: Heat shock factor 1 (HSF1) is a crucial transcription factor involved in regulating cellular heat shock response (HSR). It activates heat shock proteins (HSPs) as chaperones to correct protein folding and maintain proteostasis in response to proteotoxic stress. In addition to its role in HSR, HSF1 is often overexpressed in various cancer cells, promoting malignancy and indicating a poor prognosis. The mechanisms of HSF1-induced tumorigenesis are complex and depend on the type of cancer. Targeting HSF1 provides a novel strategy for cancer treatment.

CANCERS (2023)

Review Medicine, Research & Experimental

Targeting HSF1 for cancer treatment: mechanisms and inhibitor development

Yeh Chin, Khanisyah E. Gumilar, Xing-Guo Li, Brahmana A. Tjokroprawiro, Chien-Hsing Lu, Jianrong Lu, Ming Zhou, Robert W. Sobol, Ming Tan

Summary: HSF1 is a master regulator of heat shock responsive signaling and also regulates a non-heat shock responsive transcriptional network. It plays important roles in cellular transformation and cancer development. Research on HSF1 has been active due to its critical functions in handling stressful cellular states. New functions and molecular mechanisms have been continuously discovered, providing new targets for cancer treatment strategies. This article reviews the essential roles and mechanisms of HSF1 in cancer cells, focusing on recently discovered functions and their underlying mechanisms, as well as advances in HSF1 inhibitors for cancer drug development.

THERANOSTICS (2023)

Review Oncology

The role of ChatGPT in scientific communication: writing better scientific review articles

Jingshan Huang, Ming Tan

Summary: Artificial intelligence tools like ChatGPT provide scientists with an exciting opportunity to simplify their research and produce impactful articles. By using ChatGPT, scientists can greatly enhance the efficiency and quality of writing review articles. It speeds up writing, develops outlines, adds details, and improves writing style. However, caution must be taken as ChatGPT has limitations, and generated text should be reviewed and edited to avoid plagiarism and fabrication. Despite these limitations, ChatGPT is a powerful tool that allows scientists to focus on analyzing and interpreting literature reviews.

AMERICAN JOURNAL OF CANCER RESEARCH (2023)

No Data Available